Annual general meeting
Notice is hereby given that the 163rd annual general meeting of the
members of the Royal Pharmaceutical Society will take place in the Assembly
Hall, 1 Lambeth High Street, London SE1, on 12 May 2004, at
7.30pm.
The following business will be conducted:
1. Presentation of the annual review of the Council for 2003.
2. Presentation of the financial statements for 2003.
3. Report of revisions to the Code of Ethics and Council Statements issued
since the 2003 annual general meeting.
4. Adoption of rules of procedure for debate of motions (Byelaws, Section VI,
Paragraph 3): “A member may raise any matter or move any motion at any
annual general meeting of which he has given the Secretary notice in writing
not later than the 20th day of April in the year in which the said meeting
is to be held. The Rules of Procedure for debating such motions shall be proposed
by the Council and presented for adoption at each annual general meeting at
which such a motion is to be moved.” The proposed rules will be circulated
at the meeting.
5. Consideration of any matters raised or motions moved by members of which
notice has been given in writing no later than 20 April 2004.
(i) The following motion will be moved by Mark Walker, MRPharmS:
“That this 163rd annual general meeting of the Royal Pharmaceutical
Society of Great Britain approves the following petition:
TO THE QUEEN’S MOST EXCELLENT MAJESTY IN COUNCIL
The Humble Petition of the Members of the Royal Pharmaceutical Society of Great
Britain (hereinafter referred to as “the Members”) sheweth as
follows:
1. Her Majesty Queen Victoria was pleased by Royal Charter dated 18th
February 1843 to grant the Members a Royal Charter of Incorporation (hereinafter
referred to as “the Royal Charter of Incorporation”) and
a Common Seal.
2. Your Majesty was pleased by Royal Charter dated 19th November 1953 (hereinafter
referred to as “the Supplemental Charter of 1953”) to amend and
to add to the Royal Charter of Incorporation however the grant to the Members
of a Royal Charter of Incorporation bestowed by Her Majesty Queen Victoria
was graciously retained and continued by Your Majesty.
3. The Members humbly inform Your Majesty that the Petition dated 3rd of December
2003, signed on behalf of the Council of the Royal Pharmaceutical Society of
Great Britain and sealed with the Members’ Common Seal was submitted
to Your Majesty without the consent of the Members. The Members humbly pray
that Your Majesty rejects that Petition forthwith.
4. The Members humbly pray that Your Majesty refrain from considering all future
Petitions concerning the Royal Pharmaceutical Society of Great Britain and
retain the Supplemental Charter of 1953 until such time as a Humble Petition
is sheweth by the Members.
YOUR PETITIONERS therefore most humbly pray that Your Majesty may be
graciously pleased in the exercise of Your Royal Prerogative to grant
our Petitions and retain the Supplemental Charter of 1953 or as may seem
proper to Your Majesty.
AND YOUR PETITIONERS will ever pray etc.”
(ii) The following matter will
be raised by David Sharpe, FRPharmS:
“The procedure adopted by the Society’s Council in relation
to its proposals for a new Charter and concerns of members about the
future role of the Society as the professional representative body for
pharmacists.”
Ann Lewis
Secretary and Registrar
The following programme of events takes place on 12 May before
the AGM:
5pm
tea and sandwiches available in the hall foyer
for those attending the AGM
5.45pm
presentation of fellowship
certificates
for 2003, followed by presentation of the Charter gold and
silver medals for 2004
6.30pm
one-hour discussion forum, led
by the
President, designed to provide an informal opportunity for
members to discuss
issues of interest |
|
The
Pharmaceutical Journal